|
Omnicell, Inc. (OMCL) DCF Valuation
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Omnicell, Inc. (OMCL) Bundle
Looking to determine the intrinsic value of Omnicell, Inc.? Our (OMCL) DCF Calculator integrates real-world data with extensive customization features, enabling you to refine forecasts and enhance your investment choices.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 897.0 | 892.2 | 1,132.0 | 1,295.9 | 1,147.1 | 1,231.2 | 1,321.5 | 1,418.5 | 1,522.5 | 1,634.2 |
| Revenue Growth, % | 0 | -0.53722 | 26.88 | 14.48 | -11.48 | 7.33 | 7.33 | 7.33 | 7.33 | 7.33 |
| EBITDA | 78.4 | 107.1 | 174.4 | 96.8 | 60.7 | 120.5 | 129.3 | 138.8 | 148.9 | 159.9 |
| EBITDA, % | 8.73 | 12.01 | 15.41 | 7.47 | 5.29 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
| Depreciation | 64.1 | 71.6 | 84.9 | 99.2 | 95.6 | 95.2 | 102.2 | 109.7 | 117.7 | 126.3 |
| Depreciation, % | 7.15 | 8.02 | 7.5 | 7.65 | 8.33 | 7.73 | 7.73 | 7.73 | 7.73 | 7.73 |
| EBIT | 14.2 | 35.5 | 89.5 | -2.3 | -34.9 | 25.3 | 27.1 | 29.1 | 31.2 | 33.5 |
| EBIT, % | 1.59 | 3.98 | 7.91 | -0.17925 | -3.04 | 2.05 | 2.05 | 2.05 | 2.05 | 2.05 |
| Total Cash | 127.2 | 485.9 | 349.1 | 330.4 | 468.0 | 408.2 | 438.1 | 470.3 | 504.8 | 541.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 218.4 | 190.1 | 240.9 | 299.5 | 263.9 | 278.4 | 298.8 | 320.7 | 344.2 | 369.5 |
| Account Receivables, % | 24.34 | 21.31 | 21.28 | 23.11 | 23 | 22.61 | 22.61 | 22.61 | 22.61 | 22.61 |
| Inventories | 108.0 | 96.3 | 119.9 | 147.5 | 110.1 | 134.0 | 143.8 | 154.4 | 165.7 | 177.8 |
| Inventories, % | 12.04 | 10.79 | 10.59 | 11.39 | 9.6 | 10.88 | 10.88 | 10.88 | 10.88 | 10.88 |
| Accounts Payable | 46.4 | 40.3 | 71.5 | 63.4 | 45.0 | 61.1 | 65.6 | 70.4 | 75.6 | 81.1 |
| Accounts Payable, % | 5.17 | 4.52 | 6.32 | 4.89 | 3.93 | 4.96 | 4.96 | 4.96 | 4.96 | 4.96 |
| Capital Expenditure | -61.7 | -54.9 | -58.3 | -60.7 | -55.0 | -68.1 | -73.1 | -78.5 | -84.2 | -90.4 |
| Capital Expenditure, % | -6.87 | -6.15 | -5.15 | -4.69 | -4.8 | -5.53 | -5.53 | -5.53 | -5.53 | -5.53 |
| Tax Rate, % | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 | -1.31 |
| EBITAT | 11.8 | 39.0 | 105.6 | 5.3 | -35.3 | 19.3 | 20.8 | 22.3 | 23.9 | 25.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -265.7 | 89.6 | 89.0 | -50.5 | 59.9 | 24.2 | 24.1 | 25.8 | 27.7 | 29.8 |
| WACC, % | 7.21 | 7.39 | 7.39 | 6.34 | 7.39 | 7.14 | 7.14 | 7.14 | 7.14 | 7.14 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 106.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 31 | |||||||||
| Terminal Value | 984 | |||||||||
| Present Terminal Value | 697 | |||||||||
| Enterprise Value | 804 | |||||||||
| Net Debt | 146 | |||||||||
| Equity Value | 658 | |||||||||
| Diluted Shares Outstanding, MM | 45 | |||||||||
| Equity Value Per Share | 14.54 |
What You Will Receive
- Pre-Built Financial Model: Omnicell’s actual data facilitates accurate DCF valuation.
- Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other critical factors.
- Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
- Professional-Grade Template: An optimized Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Omnicell, Inc. (OMCL).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Omnicell, Inc. (OMCL).
- Visual Dashboard and Charts: Graphical representations highlight key valuation metrics for straightforward assessment.
How It Works
- Download the Template: Gain immediate access to the Excel-based OMCL DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
- Instant Calculations: The model automatically recalculates Omnicell's intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Omnicell, Inc. (OMCL)?
- Accurate Data: Up-to-date Omnicell financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you from starting from scratch.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Intuitive design and guided instructions make it accessible for all users.
Who Should Use Omnicell, Inc. (OMCL)?
- Healthcare Providers: Streamline medication management and improve patient safety with advanced automation solutions.
- Pharmacy Managers: Enhance operational efficiency through integrated pharmacy management systems.
- Consultants: Tailor solutions for clients to optimize their medication distribution processes.
- Healthcare Administrators: Gain insights into improving workflow and reducing costs with data-driven analytics.
- Students and Educators: Utilize real-world applications of healthcare technology in academic settings.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Omnicell, Inc. (OMCL).
- Real-World Data: Omnicell’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Full annual and quarterly breakdowns for deeper insights into Omnicell’s performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Omnicell, Inc. (OMCL).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results focused on Omnicell’s metrics.